L. Pressley
Royal Prince Alfred Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. Pressley.
International Journal of Cardiology | 1996
Atul D. Abhyankar; N.S. Mok; G.A. Helprin; L. Pressley
Coronary pulmonary fistulae are rare cardiac anomalies. We present the case of a 46-year-old woman with multiple coronary-pulmonary fistulae involving all three coronary arteries. She presented with atypical chest pain and had no obstructive coronary lesion. SPECT thallium study demonstrated no perfusion defect. The fistulae were multiple but small with only a small left to right shunt (Qp:Qs = 1.2). The patient has remained well without intervention.
Open Heart | 2017
Mark Dennis; Ben Moore; Irina Kotchetkova; L. Pressley; Rachael Cordina; David S. Celermajer
Objective Survival of patients with repaired tetralogy of Fallot (rToF) into young adulthood is very good. Concerns exist, however, over long-term morbidity and mortality as these subjects reach middle age. We aimed to assess survival and the prevalence of complications in patients with rToF seen in our Adult Congenital Heart Disease (ACHD) service. Methods One hundred and sixty-eight consecutive patients with ‘simple rToF’, aged over 16 years, followed up at our tertiary-level ACHD service in Sydney, Australia since 2000, were included. We documented mortality and analysed the prospectively defined composite end points of (a) ‘Serious adverse events’, including death, heart failure hospitalisation and/or documented ventricular arrhythmia and (b) ‘Adverse events’ inclusive of the above and endocarditis, atrial arrhythmia, defibrillator and/or pacemaker implantation. Results Mean age at the last follow-up was 34±12 years, and 55% were men. There were 10 (6%) deaths, and 26 patients (16%) experienced a ‘serious adverse event’. Fifty-one patients (30%) experienced an ‘adverse event’ and 29 patients had atrial arrhythmias. One hundred and one (61%) patients had at least one pulmonary valve replacement. By age 40 years, 93% were free of serious adverse events, and 83% were free of any adverse event. By age 50 years, only 56% had not had an adverse event. Older age and history of atrial arrhythmia were predictive of serious adverse events. Conclusion Survival into mid-adulthood in patients with rToF is very good; however, a substantial number of survivors have adverse events by the age of 50 years.
Open Heart | 2016
A McCombe; F Touma; D. Jackson; Carla Canniffe; Preeti Choudhary; L. Pressley; D. Tanous; Peter J. Robinson; David S. Celermajer
Background Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital heart disease. There have been only few reports of sudden cardiac death (SCD) in patients with ccTGA and reasonable ventricular function. Methods A retrospective review of the medical records of all patients attending our adult congenital heart centre, with known ccTGA. Results From a database of over 3500 adult patients with congenital heart disease, we identified 39 (∼1%) with ccTGA and ‘two-ventricle’ circulations. 65% were male. The mean age at diagnosis was 12.4±11.4 years and the mean age at last time of review was 34.3±11.3 years. 24 patients (56%) had a history of surgical intervention. 8 (19%) had had pacemaker implantation and 2 had had a defibrillator implanted for non-sustained ventricular tachycardia (NSVT). In 544 years of patient follow-up, there had been five cases of SCD in our population; 1 death per 109 patient-years. Two of these patients had had previously documented supraventricular or NSVT. However, they were all classified as New York Heart Association (NYHA) class I or II, and systemic (right) ventricular function had been recorded as normal, mildly or mildly–moderately impaired, at most recent follow-up. Conclusions Our experience suggests the need for improved risk stratification and/or surveillance for malignant arrhythmia in adults with ccTGA, even in those with reasonable functional class on ventricular function.
Heart Lung and Circulation | 2018
Mugur Nicolae; T. Gentles; G. Strange; D. Tanous; Patrick Disney; Andrew Bullock; Leeanne Grigg; Sylvia S.M. Chen; L. Pressley; Rachael Cordina; Tim Hornung; Clare O’Donnell; David S. Celermajer
BACKGROUND Adult congenital heart disease (ACHD) is a relatively new subspecialty in the cardiology field. The prevalence of ACHD is estimated at ∼ 3,000 per million adult population. The ACHD patient group is estimated to grow at ∼ 5% per year and in the next decade it is forecast that 1 in 150 young adults will carry some form of ACHD diagnosis. These estimates translate to ∼ 72,000 ACHD patients in Australia and ∼ 14,000 in New Zealand, although no current numbers are available. The Cardiac Society of Australia and New Zealand (CSANZ) has recently published Recommendations for Standards of Care for Adult Congenital Heart Disease (ACHD) in 2016. There is currently no long-term plan or proposal to address this huge health care burden within the federal government. This document details the size of the problem insofar as it is known and recommends solutions to be implemented. METHODS This document was developed by the Adult Congenital Heart Disease Working Group of the Paediatric and Congenital Council (the Congenital Heart Alliance of Australia and New Zealand) as a response to the chronic under resourcing in this area, the risk this poses to patients and clinicians, and the clear need for long-term planning to develop safe care pathways. RESULTS These issues were raised with the CSANZ Board in December 2015 and the document was developed in response to the Boards request for more information. The current iteration was finalised on 14 November 2017. CONCLUSIONS The authorship group comprised participants in the CSANZ adult CHD standards of care recommendations from 2013 with the inclusion of some newly trained ACHD cardiologists, who represented most states and territories across ANZ. None of the authors has any academic or professional conflict of interest.
Heart Lung and Circulation | 2007
Rajesh Puranik; Kim Greaves; R E Hawker; L. Pressley; Peter J. Robinson; David S. Celermajer
European Heart Journal | 2018
Rachael Cordina; Subha Nasir Ahmad; Irina Kotchetkova; Gry Eveborn; L. Pressley; Julian Ayer; Richard Chard; D. Tanous; Peter J. Robinson; Jens G. Kilian; John Deanfield; David S. Celermajer
International Journal of Cardiology | 2014
Mark Dennis; Maarit Laarkson; Ratnasari Padang; D. Tanous; Peter J. Robinson; L. Pressley; Shamus O'Meagher; David S. Celermajer; Rajesh Puranik
Heart Lung and Circulation | 2004
M. Puvaneswary; G. Warner; L. Pressley; R. Hawker
Heart Lung and Circulation | 2016
Mark Dennis; Benjamin M. Moore; Irina Kotchetkova; L. Pressley; D. Tanous; Rachael Cordina; David S. Celermajer
Global heart | 2014
Preeti Choudhary; C. Hamilton-Craig; W. Strugnell; Peter J. Robinson; L. Pressley; D. Tanous; Rajesh Puranik; David S. Celermajer